IPCALAB

NSE#489 by turnover

IPCA Laboratories Limited

₹1,970.80-26.30 (-1.32%)Close, 25 Sept 2026

Key statistics

Open: ₹2,020.00
Day range: 1,950.00 – 2,020.00
52-week range: 1,251.60 – 2,038.00
From 52w high: -3.3%
Volume: 2.64L
Turnover: ₹52.0Cr
Delivery: 55.1%
Rel volume: 1.09×
RSI (14): 55.4
ATR (14): 54.94
SMA 50: 1,875.04
SMA 200: 1,619.56

Performance

1 day: -1.32%
1 week: -1.93%
1 month: +0.94%
3 months: +19.65%
6 months: +28.82%
1 year: +46.99%

Delivery percentage

Latest: 55.1%
20-day avg: 55.3%
1-year avg: 49.1%
Percentile: 68th
Range: 11.8–93.9%

Over the last 20 sessions IPCALAB settled 55.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 49.1%, so recent sessions are running 6.2 points higher than usual. The latest session ranks higher than 68% of the 1,725 sessions on record for it.

What delivery percentage measures Scan the whole market on delivery

Fundamentals

Market cap: ₹50,000 Cr
P/E (TTM): 36.36
EPS (TTM): ₹54.20
Shares outstanding: 25.37Cr
Listed: 8 Feb 1995

Classification

Macro sector: Healthcare
Sector: Healthcare
Industry: Pharmaceuticals & Biotechnology
Basic industry: Pharmaceuticals

NSE publishes no history for this taxonomy, so it is today’s classification rather than the one that held in the past.

Growthlatest filed quarter Q1 FY27

Revenue YoY: +20.76%
Profit YoY: +82.18%
Revenue QoQ: +16.73%
Profit QoQ: +38.34%
Interest cost YoY: —

Compound growth

Not enough filed history for a compound growth rate yet.

Trailing-twelve-month figures against the same measure that many years earlier, on one reporting basis throughout. Blank where the filed history is too short or either end of the window was a loss — never a number built from less.

About

ISIN: INE571A01038
Series: EQ
History from: 2 Jan 1995
Sessions: 7,830

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 25 Sept 2026.